Skip to main content

Table 2 Mean (±sd) hematological parameter values of omega-3 fatty acid treated, hydroxyurea treated and untreated patients (HbSS) and healthy controls

From: Coagulation profile of Sudanese children with homozygous sickle cell disease and the effect of treatment with omega-3 fatty acid on the coagulation parameters

  Omega-3 FA Treated Patients Untreated patients HU Treated Healthy Controls
Hb (g/l) 75.6 ± 16.2*** 75.9 ± 10.3+++ 79.5 ± 10.3 126.0 ± 10.9
HCt 22.9 ± 4.7*** 22.9 ± 3.0+++ 23.8 ± 2.8 38.0 ± 3.5
RBC 2.8 ± 0.7*** 2.7 ± 0.5+++ 2.8 ± 0.6 4.6 ± 0.5
MCV (fl) 84.3 ± 8.6 86.5 ± 7.1 87.8 ± 11.6 82.3 ± 4.7
MCH (pg) 27.9 ± 3.4 28.6 ± 3.0 29.5 ± 4.4 27.6 ± 1.9
MCHC 33.3 ± 2.0 33.1 ± 1.4 33.4 ± 0.9 33.5 ± 1.5
PLT 489.5 ± 121.1*** 533.6 ± 98.7+++ 414.5 ± 109.9× 330.3 ± 72.5
WBC 12.4 ± 4.3*** 13.3 ± 3.4+++ 13.6 ± 3.7 6.3 ± 1.3
  1. ***p < 0.001 Omega 3 treated versus healthy controls
  2. ++p < 0.01, +++p < 0.001 Untreated patients versus healthy controls
  3. x p < 0.05, HU treated versus untreated patients
Back to article page

BMC Hematology

ISSN: 2052-1839

Contact us